Portosystemic shunt (PSS) — also known as a liver shunt — in dogs is a medical condition that affects the normal flow of blood through the liver. Under typical circumstances, blood from the intestine, ...

Shifamed portfolio company Adona Medical has raised $33.5m in a Series C financing round for supporting the next stage of product development and initiating clinical use of its interatrial shunt and ...

NEWARK, Del, Feb. 20, 2024 (GLOBE NEWSWIRE) -- According to Future Market Insights’ latest industry analysis, the Hydrocephalus Shunt Market size is estimated to be around US$ 546.09 million in 2024.

For babies born with a certain heart defect, implantation of a "shunt" is essential to their survival. A new type of shunt can be expanded using light after it's been implanted, potentially ...

10 patients enrolled with 100% implantation success Adona's adjustable interatrial shunt is designed so it can be modified post-implantation to provide a more adaptive and personalized lifetime ...

HINGHAM, Mass., Sept. 10, 2019 (GLOBE NEWSWIRE) -- Having successfully concluded an independent in-vitro laboratory study and published the positive results earlier this year, the operational ...

LOS GATOS, Calif., Oct. 27, 2024 /PRNewswire/ -- Adona Medical, a Shifamed portfolio company that aims to deliver advanced solutions for heart failure, announced today the successful first-in-human ...

Children born with defects that impair the heart's lower chambers undergo a series of invasive surgeries early in life. The first surgery includes implantation of a plastic tube called a shunt to ...

HINGHAM, Mass., June 14, 2017 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq:MBOT), a medical device company specializing in the design and development of transformational micro-robotic medical ...